MediTox s.r.o.


RESEARCH PROJECTS

EU Framework Programmes

Selected projects:

MuLeVaClin: Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis

Participating countries: Czech Republic, France, Germany, Norway, Russia, Switzerland


UniVax: “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines

Participating countries: Czech Republic, Italy, Portugal, Spain, Switzerland


HELICOVAXOR: Development of an Oral Helicobacter Pylori Vaccine

Participating countries: United Kingdom, Czech Republic, Irland, Sweden, Switzerland


MOTIF: Microbicide Optimization Through Innovative Formulation for Vaginal and Rectal Delivery

Participating countries: United Kingdom (King´s College London), Czech Republic, France, Italy, USA


CHIMERIC VACCINES: Development of influenza delNS1 virus as a vector for foreign antigens

Participating countries: Austria, Czech Republic, Germany, Russia , Slovenia


SARS/FLU VACCINE:Development of a combined Influenza/SARS Vaccine

Participating countries: Austria, Czech Republic, Germany, Russia, Slovenia


FLUVACC: Live attenuated replication-defective influenza vaccine)

Participating countries: Austria, Czech Republic, Germany, Russia, Slovenia


H5 VACCINE: Immunogenicity and protective efficacy of intranasal delNS1/H5N1 influenza vaccine

Participating countries: Austria, Czech Republic, Germany, Russia, United Kingdom


ANTIFLU: Innovative anti-influenza drugs excluding viral escape

Participating countries: Germany, Czech Republic, Denmark, France, Hungary, Israel, The Nethelrands, United Kingdom


OSTEOGROW: Novel bone morphogenetic protein-6 biocompatible carrier device for bone regeneration

Participating countries: Croatia, Austria, Bosnia and Herzegovina, Czech Republic, Sweden


FLUniversal: Intranasal, rapid acting universal influenza vaccine

Participating countries: Austria, Czech Republic, Denmark, Italy, The Netherland, UK


Technology Agency of the Czech Republic

Selected projects:

TE01020028 - CDOD: Center for Development of Original Drugs

Participants: IOCB CAS, Apigenex, MediTox, FGI CAS, IMTM, Quinta-Analytica, IEM CAS, ICHT


TA01011466 - BIOMEDTEST: Biomedical models of traumatic spinal cord injury and neurodegenerative diseases in miniature pigs for testing of new therapeutic approaches

Participants: MediTox s.r.o., Institute of animal Physiology and Genetics CAS